Patent directory · USPTO A61K / A61P
Patents matching “formulation”
865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9783515
Radiomitigating pharmaceutical formulations
granted -
US 9782416
Pharmaceutical formulations of potassium ATP channel openers and uses thereof
granted -
US 9775900
Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof
granted -
US 9770414
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
granted -
US 9770510
Etanercept formulations stabilized with xylitol
granted -
US 9770507
Stable aqueous formulations of adalimumab
granted -
US 9763883
Abuse-deterrent drug formulations
granted -
US 9757454
Stable aqueous formulations of adalimumab
granted -
US 9758465
Controlled release pharmaceutical formulations
granted -
US 9757483
Labeled iodinated tropane formulation
granted -
US 9757354
Therapeutic formulations and methods
granted -
US 9744142
Formulations of volatile anesthetics and methods of use for reducing inflammation
granted -
US 9737530
Process of making stable abuse-deterrent oral formulations
granted -
US 9737600
Stable aqueous formulations of adalimumab
granted -
US 9731009
Stable aqueous formulations of adalimumab
granted -
US 9731008
Stable aqueous formulations of adalimumab
granted -
US 9724345
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 9724367
Injectable formulations for organ augmentation
granted -
US 9724414
Stable aqueous formulations of adalimumab
granted -
US 9724415
Stable aqueous formulations of adalimumab
granted -
US 9713599
Parenteral formulations of treprostinil
granted -
US 9707284
Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases
granted -
US 9707293
Stable aqueous formulations of adalimumab
granted -
US 9687448
Nucleic acid lipid particle formulations
granted